Delivery Order SPE2DR25D1004-SPE2DR26FSWB5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $1,172.18 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units. This is a firm fixed price order with completion targeted for November 18, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $3,971.72 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be executed from...
- The Defense Logistics Agency awarded a $2,172.97 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on August 29, 2025, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,429.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on November 24, 2025, with completion scheduled for November 25, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running...
- The Defense Logistics Agency awarded a $1,606.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a contract value of $39,828.37. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025. The contract was competitively awarded with no set-aside designation, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. As a child order, this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,265.11 on November 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $19,070.71 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $2,306.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSWB5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,362.53 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on December 4, 2025, with completion scheduled for December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's extensive pharmaceutical supply capabilities to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to military and veteran healthcare systems. Jardiance, a diabetes management medication, exemplifies the breadth of therapeutic products the company supplies through this comprehensive contract. AmerisourceBergen's status as a major pharmaceutical distributor and critical vendor for federal medical procurement, combined with its demonstrated ability to fulfill competitive federal requirements, positions it as a key supplier for the Defense Health Agency and other federal healthcare stakeholders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/3/25 |